Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


Digital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype.

Angell HK, Gray N, Womack C, Pritchard DI, Wilkinson RW, Cumberbatch M.

Br J Cancer. 2013 Sep 17;109(6):1618-24. doi: 10.1038/bjc.2013.487. Epub 2013 Aug 20.


The in situ local immune response, tumour senescence and proliferation in colorectal cancer.

Roxburgh CS, Richards CH, Macdonald AI, Powell AG, McGlynn LM, McMillan DC, Horgan PG, Edwards J, Shiels PG.

Br J Cancer. 2013 Oct 15;109(8):2207-16. doi: 10.1038/bjc.2013.556. Epub 2013 Sep 10.


Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.

Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.


Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer.

Bauer K, Michel S, Reuschenbach M, Nelius N, von Knebel Doeberitz M, Kloor M.

Fam Cancer. 2011 Sep;10(3):557-65. doi: 10.1007/s10689-011-9449-7.


Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy.

Halama N, Michel S, Kloor M, Zoernig I, Benner A, Spille A, Pommerencke T, von Knebel DM, Folprecht G, Luber B, Feyen N, Martens UM, Beckhove P, Gnjatic S, Schirmacher P, Herpel E, Weitz J, Grabe N, Jaeger D.

Cancer Res. 2011 Sep 1;71(17):5670-7. doi: 10.1158/0008-5472.CAN-11-0268. Epub 2011 Aug 16.


Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis.

Mei Z, Liu Y, Liu C, Cui A, Liang Z, Wang G, Peng H, Cui L, Li C.

Br J Cancer. 2014 Mar 18;110(6):1595-605. doi: 10.1038/bjc.2014.46. Epub 2014 Feb 6. Review.


Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor.

Allard MA, Bachet JB, Beauchet A, Julie C, Malafosse R, Penna C, Nordlinger B, Emile JF.

Diagn Pathol. 2012 Nov 13;7:156. doi: 10.1186/1746-1596-7-156.


Clinical implications of the tumor-infiltrating lymphocyte subsets in colorectal cancer.

Liao Y, Ou J, Deng J, Geng P, Zeng R, Tian Y, Liang H, Ni B, Ruan Z.

Med Oncol. 2013 Dec;30(4):727. doi: 10.1007/s12032-013-0727-0. Epub 2013 Sep 13.


CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

Laghi L, Bianchi P, Miranda E, Balladore E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A, Santoro A, Mantovani A, Roncalli M, Malesci A.

Lancet Oncol. 2009 Sep;10(9):877-84. doi: 10.1016/S1470-2045(09)70186-X. Epub 2009 Aug 3.


The clinical utility of the local inflammatory response in colorectal cancer.

Richards CH, Roxburgh CS, Powell AG, Foulis AK, Horgan PG, McMillan DC.

Eur J Cancer. 2014 Jan;50(2):309-19. doi: 10.1016/j.ejca.2013.09.008. Epub 2013 Oct 5.


An improved image analysis method for cell counting lends credibility to the prognostic significance of T cells in colorectal cancer.

Väyrynen JP, Vornanen JO, Sajanti S, Böhm JP, Tuomisto A, Mäkinen MJ.

Virchows Arch. 2012 May;460(5):455-65. doi: 10.1007/s00428-012-1232-0. Epub 2012 Apr 24.


Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.

Gulubova M, Manolova I, Kyurkchiev D, Julianov A, Altunkova I.

APMIS. 2009 Dec;117(12):870-9. doi: 10.1111/j.1600-0463.2009.02547.x.


Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer.

Chaput N, Svrcek M, Aupérin A, Locher C, Drusch F, Malka D, Taïeb J, Goéré D, Ducreux M, Boige V.

Br J Cancer. 2013 Aug 20;109(4):1013-22. doi: 10.1038/bjc.2013.362. Epub 2013 Jul 18.


Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.

Shimabukuro-Vornhagen A, Schlößer HA, Gryschok L, Malcher J, Wennhold K, Garcia-Marquez M, Herbold T, Neuhaus LS, Becker HJ, Fiedler A, Scherwitz P, Koslowsky T, Hake R, Stippel DL, Hölscher AH, Eidt S, Hallek M, Theurich S, von Bergwelt-Baildon MS.

Oncotarget. 2014 Jul 15;5(13):4651-64.


Effector memory T cells, early metastasis, and survival in colorectal cancer.

Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J.

N Engl J Med. 2005 Dec 22;353(25):2654-66.


Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity.

Green VL, Michno A, Stafford ND, Greenman J.

Cancer Immunol Immunother. 2013 May;62(5):863-73. doi: 10.1007/s00262-013-1395-9. Epub 2013 Jan 29.


Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B.

J Clin Oncol. 2009 Jan 10;27(2):186-92. doi: 10.1200/JCO.2008.18.7229. Epub 2008 Dec 8.


Prognostic significance of beta-catenin in colorectal cancer with liver metastasis.

Han SA, Chun H, Park CM, Kang SJ, Kim SH, Sohn D, Yun SH, Lee WY.

Clin Oncol (R Coll Radiol). 2006 Dec;18(10):761-7. Erratum in: Clin Oncol (R Coll Radiol). 2007 May;19(4):270-1.


Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue.

Sherwood AM, Emerson RO, Scherer D, Habermann N, Buck K, Staffa J, Desmarais C, Halama N, Jaeger D, Schirmacher P, Herpel E, Kloor M, Ulrich A, Schneider M, Ulrich CM, Robins H.

Cancer Immunol Immunother. 2013 Sep;62(9):1453-61. doi: 10.1007/s00262-013-1446-2. Epub 2013 Jun 16.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk